AHCA Logo

LIP/DSH/GME Operations

The LIP/DSH/GME Operations Unit contracts with local Intergovernmental entities (e.g. Counties, Taxing Districts, and Hospital Taxing Districts) to fund the state share for the supplemental payment programs.  The unit manages supplemental payment funding distributions and monitor state and federal compliance of the Low Income Pool (LIP) program, Disproportionate Share Hospital (DSH) program, Graduate Medical Education (GME) program, Medicaid School Faculty Physicians payments, Public Emergency Medical Transportation (PEMT) program, and the Florida Cancer Hospital (FCHP) program.

LIP

The LIP program allocates $1.5 billion to ensure the continued governmental support for the safety net providers that furnish uncompensated charity care to the uninsured populations. This funding includes a combination of both Intergovernmental Transfers (IGTs) and federal dollars.

DSH

The DSH program distributes $326 million of combined funding from IGTs and federal dollars. DSH funding is used to compensate hospitals that have provided a disproportionate share of Medicaid and/or charity care services.

GME

The Graduate Medical Education (GME) Statewide Medicaid Residency Program consists of $97.3 million used to provide funding to qualified participating hospitals involved in graduate medical education.  Additionally, the GME Startup Bonus Program provides $100 million to qualifying hospitals with newly approved residency positions in the statewide supply-and-demand deficit specialties.

PEMT

The Public Emergency Medical Transportation (PEMT) certified public expenditure (CPE) program for Emergency Medical Services provides $35 million to public entities for the provision of emergency transportation services to Medicaid fee-for-service beneficiaries.

FCHP

The Florida Cancer Hospital Program (FCHP) was created to give eligible providers an enhanced reimbursement for inpatient and outpatient hospital services. The Centers for Medicare and Medicaid Services (CMS) approved the State Plan Amendment (SPA) on March 8, 2018 with an effective date of October 26, 2017.